Question-and-Answer SessionBut a lot going on at Neurocrine, Matt, can you give us a quick snapshot of the highlights of 2025 that we've passed or are yet to come.Matthew AbernethyChief Financial Officer Well, thanks, Josh, and we will be making forward-looking statements, so I'll get that out there. Yes, happy to be here. A lot going on for Neurocrine. And hopefully, this is Eric. We have an open chair here. A lot going on for Neurocrine. INGREZZA is going quite well, $2.5 billion in sales is what we expec ...

Question-and-Answer SessionMaybe for those who might be a little bit newer to Appian, can you just give a little background on the company and what is it that Appian does?Srdjan TanjgaChief Financial Officer Excellent. It's no better place to start. So Appian is a platform that allows customers to automate and orchestrate their most important enterprise processes. So that's a mouthful. So maybe the best way to explain that is through a few examples. So for example, one of our largest customers is a global p ...

Question-and-Answer SessionBrendan and Marcos, maybe a good place to start. You had some recent news. You recently announced the acquisition of an incremental 25% ownership in McCormick de Mexico. Maybe you can walk through the sort of the strategic rationale for the deal, financial impact on total McCormick following the close of the transaction.Brendan FoleyPresident, CEO & Chairman We're excited about this transaction, and it's been part of our pipeline for a long time. So we were really thrilled to get ...

Core Points - The first phase of ticket sales for the FIFA World Cup 26 will open with the Visa Presale Draw on September 10, 2025 [1][3] - Fans must register for a FIFA ID to participate in the ticketing process and will be notified about sale dates [2][4] - Group-stage tickets will start at USD 60, while exclusive final match tickets can reach up to USD 6,730 [6] Ticket Sales Phases - The Visa Presale Draw entry period is from September 10 to September 19, 2025, with successful applicants notified by September 29 [3][5] - Subsequent ticket sales phases will include an Early Ticket Draw from October 27 to 31, 2025, and a Random Selection Draw after the Final Draw [9] - Closer to the tournament, remaining tickets will be available on a first-come, first-served basis [10] Additional Ticketing Information - A secure resale platform for eligible ticket holders will be launched later this year to prevent unauthorized resales [11] - Fans can purchase hospitality packages at FIFA.com/hospitality, and are encouraged to buy tickets only through official channels [12]

Group 1 - The core announcement is about Diagnos Inc. conducting a non-brokered private placement of 10 units at a price of $10,000 per unit, aiming for gross proceeds of $100,000 [1][2] - Each unit consists of an unsecured convertible debenture with a 12-month term and an annual interest rate of 10%, which can be converted into common shares at a price of $0.28 per share [1][2] - Additionally, each warrant allows the holder to purchase one share at a price of $0.40 per share during the term [2] Group 2 - The proceeds from the private placement will primarily fund product development and commercialization of AI-based screening services, along with general and administrative expenses [2] - A director of the corporation has committed to subscribe for all units in the private placement [2] - All securities issued will be subject to a 4-month statutory hold period and require approval from the TSX Venture Exchange [3] Group 3 - Diagnos Inc. is focused on early detection of critical eye-related health issues using advanced AI technology to enhance diagnostic accuracy and improve patient outcomes globally [4]

My take is that The Campbell's Company's ( CPB ) fiscal Q4 2025 results show a company under pressure, but also one with hidden strengths that the market, judging by today’s positive reaction,I focus on producing objective, data-driven research, mostly about small- to mid-cap companies, as these tend to be overlooked by many investors. From time to time, though, I also look at large-cap names, just to give a fuller sense of the broader equity markets.Analyst’s Disclosure:I/we have no stock, option or simila ...

Company Overview - Ensurge Micropower ASA is focused on developing ultrathin, flexible, reliable, and fundamentally safe solid-state lithium microbatteries [2][3] - The company operates with a workforce of forty specialists located in Silicon Valley, emphasizing innovation in microbattery technology suitable for various applications [3] Recent Developments - On August 29, 2025, the Board of Directors granted 30,687,311 incentive subscription rights to CEO Shauna McIntyre under the 2025 Incentive Subscription Rights Plan [1] - A subscription transaction took place on September 3, 2025, with further details provided in an enclosed form [2] Manufacturing and Production - Ensurge's manufacturing facility utilizes patented process technology and materials innovation, optimized for roll-to-roll production methods [4] - The company aims to outsource production of its intellectual property to specialized partners to scale efficiently [4] Financial and Market Position - Ensurge is listed on the Norwegian stock exchange and is financed by reputable financial investors, indicating a strong strategic investment and transatlantic collaboration [5]

Question-and-Answer SessionSo we have some things to discuss without a question, how to throw out the old sort of fireside chat questions and come up with some new ones, but we appreciate you sort of being here even in the midst of all that you've got going on. Maybe to start off at sort of a basic level, right, yesterday morning, you announced you're going to plan to split the business into 2 separate entities, Global Taste Elevation Co., North American Grocery Co. So to start, why do you believe the separ ...

Core Insights - The storage market has experienced significant evolution since the beginning of the year, influenced by various demand indicators and macroeconomic factors [1] Demand Outlook - There have been multiple factors affecting demand, including tariffs and specific market dynamics such as DeepSeek [1] - The company is reflecting on how the demand outlook has changed over the past few months, indicating a more nuanced understanding of market conditions [1]

PresentationI will now turn the call over to Kate Rausch, Vice President of Corporate Affairs and Investor Relations.Good morning, and welcome to the Wave Life Sciences RestorAATion-2 Clinical Update Conference Call. [Operator Instructions] Also, as a reminder, this conference call is being recorded today.Kate RauschHead of Investor Relations Thank you, operator. This morning, we issued a press release announcing a positive update from our ongoing RestorAATion-2 trial of WVE-006 in alpha-1 antitrypsin defic ...